Merz announced today the U.S. Food and Drug Administration (FDA) has cleared Cellfina’s® new indication statement that shows the benefits of Cellfina last for five years, an...
Garwood Medical Devices has secured breakthrough device designation from the US Food and Drug Administration (FDA) for its BioPrax biofilm disruption device. BioPrax is a minimally...
Medical devices maker Alphatec has commercially introduced its porous titanium line of IdentiTi implants for lateral interbody fusion (LIF) procedures. The commercial launch of IdentiTi LIF...
US-based speech generating devices provider Tobii Dynavox has unveiled the next generation of the I-Series, a communication device featuring the company’s latest eye tracking sensor IS5....
Talaris Therapeutics, Inc., a privately held biotechnology company developing transformative cell therapies that have the potential to eliminate the burden of chronic immunosuppression for organ transplant...
Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely...
Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), a biopharmaceutical company focused on developing and commercializing medicines seeking to improve the survival and quality of life...
Swiss drugmaker Novartis (NOVN.S) boosted its 2019 forecasts on Tuesday after beating third-quarter expectations, a feat helped by the sales debut of gene therapy Zolgensma, the...
Centene Corporation (NYSE: CNC) (“Centene”) and WellCare Health Plans, Inc. (NYSE: WCG) (“WellCare”) today announced that the New York Department of Financial Services and Department of Health have...
HCmed Innovations Co., Inc., a drug-device combination company focused on inhalation therapy, presented its latest brand, Pulmogine, in the 2019 ERS International Congress. Pulmogine, a mesh nebulizer...
Bayer a leader in women’s healthcare, announced today the submission of a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration (FDA) to potentially...
The U.S. Food and Drug Administration (FDA) green-lit Janssen’s Stelara for the treatment of adult patients with moderately to severely active ulcerative colitis after clinical trials demonstrated the drug...
Achilles Therapeutics (“Achilles”), a biopharmaceutical company developing personalised cancer immunotherapies, today announces it has appointed Beverley Carr as Chief Business Officer, with effect from 4 November 2019....
Carlisle Companies has signed an agreement to acquire US-based Providien, a provider of comprehensive manufacturing solutions to the medical device original equipment manufacturers (OEMs). The company...
ResMed has launched AirFit N30, which is claimed to be the world’s first tube-down nasal cradle CPAP mask. Designed for sleep apnea treatment, the AirFit N30...
Copyright © 2024 Medical Buyer